HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ketoconazole in the treatment of vaginal candidiasis.

Abstract
In a preliminary open prospective study ketoconazole (Nizoral; Janssen) 200 mg twice daily for 5 consecutive days was found to be extremely effective in treating vulvovaginal candidiasis, producing cure rates of 96% at 7 days and 92% at 28 days. The oral route of administration has definite advantages over the vaginal route and improves patient compliance. No side-effects related to treatment were found in this study.
AuthorsB Bloch, E Smythe
JournalSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde (S Afr Med J) Vol. 67 Issue 5 Pg. 178-9 (Feb 02 1985) ISSN: 0256-9574 [Print] South Africa
PMID3983757 (Publication Type: Journal Article)
Chemical References
  • Ketoconazole
Topics
  • Administration, Oral
  • Adult
  • Candidiasis, Vulvovaginal (drug therapy)
  • Female
  • Humans
  • Ketoconazole (administration & dosage, therapeutic use)
  • Pilot Projects
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: